11/7
08:00 am
qnrx
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results
Medium
Report
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results
11/5
08:00 am
qnrx
Quoin Pharmaceuticals Initiates Clinical Testing of Lead Product in Pediatric Netherton Syndrome Patient
Neutral
Report
Quoin Pharmaceuticals Initiates Clinical Testing of Lead Product in Pediatric Netherton Syndrome Patient
10/31
04:05 pm
qnrx
Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024
Low
Report
Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024
10/22
08:00 am
qnrx
Quoin Pharmaceuticals Announces Further International Expansion of Ongoing Clinical Trials for Netherton Syndrome
High
Report
Quoin Pharmaceuticals Announces Further International Expansion of Ongoing Clinical Trials for Netherton Syndrome
9/9
10:31 am
qnrx
Quoin Pharmaceuticals announces insider share purchases [Seeking Alpha]
High
Report
Quoin Pharmaceuticals announces insider share purchases [Seeking Alpha]
9/9
08:30 am
qnrx
Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO
High
Report
Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO